Literature DB >> 18360126

Complete regression of primary malignant melanoma.

Patrick O Emanuel1, Meghan Mannion, Robert G Phelps.   

Abstract

Over the years, histopathologic studies to determine the nature and significance of regression in malignant melanoma have yielded different results. At least in part, this most likely reflects differences in the definition of what constitutes regression. Although partial regression is relatively common, complete regression is rare. It has been said that complete regression of a primary lesion is associated with metastatic disease, but the evidence for this is largely anecdotal-the literature contains only case reports and small series. We found 2 cases of complete regression in our dermatopathology database. Metastatic disease was identified in both cases; in 1 case, the suspicion of melanoma was raised on the initial biopsy and subsequent workup revealed lymph node metastasis. These cases illustrate the histologic features of a completely regressed primary melanoma and add credence to the theory that completely regressed melanoma is associated with a poor outcome.

Entities:  

Mesh:

Year:  2008        PMID: 18360126     DOI: 10.1097/DAD.0b013e318165641a

Source DB:  PubMed          Journal:  Am J Dermatopathol        ISSN: 0193-1091            Impact factor:   1.533


  13 in total

1.  Regression in primary cutaneous melanoma: etiopathogenesis and clinical significance.

Authors:  Phyu P Aung; Priyadharsini Nagarajan; Victor G Prieto
Journal:  Lab Invest       Date:  2017-02-27       Impact factor: 5.662

2.  Management decisions for nodal metastasis from an unknown primary melanoma.

Authors:  Chris C Lee; Mark B Faries; Donald L Morton
Journal:  Am J Hematol Oncol       Date:  2008-07-01

3.  High lymphatic vessel density and lymphatic invasion underlie the adverse prognostic effect of radial growth phase regression in melanoma.

Authors:  Sook Jung Yun; Phyllis A Gimotty; Wei-Ting Hwang; Peter Dawson; Patricia Van Belle; David E Elder; Rosalie Elenitsas; Lynn Schuchter; Paul J Zhang; DuPont Guerry; Xiaowei Xu
Journal:  Am J Surg Pathol       Date:  2011-02       Impact factor: 6.394

4.  Primary malignant melanoma of the lung: A case report.

Authors:  Yoko Yamamoto; Ken Kodama; Tomohiro Maniwa; Masashi Takeda; Yuuka Tanaka; Kentaro Ozawa; Taiki Isei
Journal:  Mol Clin Oncol       Date:  2017-05-10

5.  Identification of a Germline Pyrin Variant in a Metastatic Melanoma Patient With Multiple Spontaneous Regressions and Immune-related Adverse Events.

Authors:  Cameron J Oswalt; Rami N Al-Rohil; Bala Theivanthiran; Tarek Haykal; April K S Salama; Nicholas C DeVito; Alisha Holtzhausen; Dennis C Ko; Brent A Hanks
Journal:  J Immunother       Date:  2022-05-30       Impact factor: 4.912

Review 6.  Novel Therapies for Metastatic Melanoma: An Update on Their Use in Older Patients.

Authors:  Aljosja Rogiers; Joost J van den Oord; Marjan Garmyn; Marguerite Stas; Cindy Kenis; Hans Wildiers; Jean-Christophe Marine; Pascal Wolter
Journal:  Drugs Aging       Date:  2015-10       Impact factor: 3.923

7.  Primary melanoma of the adrenal gland: a case report and review of the literature.

Authors:  Luis González-Sáez; Salvador Pita-Fernández; Maria José Lorenzo-Patiño; Francisco Arnal-Monreal; José Machuca-Santacruz; José Romero-González
Journal:  J Med Case Rep       Date:  2011-07-02

8.  The curious incident of 3 melanomas and their possible origins-A case report and review of literature.

Authors:  Eliza I-Lin Sin; Benita Kiat Tee Tan; Kah Weng Lau; Melissa Ching-Ching Teo
Journal:  Int J Surg Case Rep       Date:  2016-04-13

9.  Metastatic melanoma with spontaneous complete regression of a thick primary lesion.

Authors:  Hasan Khosravi; Andressa L Akabane; Allireza Alloo; Rosalynn M Nazarian; Genevieve M Boland
Journal:  JAAD Case Rep       Date:  2016-12-03

10.  Variations in the expression of TIMP1, TIMP2 and TIMP3 in cutaneous melanoma with regression and their possible function as prognostic predictors.

Authors:  Sabina Zurac; Monica Neagu; Carolina Constantin; Mirela Cioplea; Roxana Nedelcu; Alexandra Bastian; Cristiana Popp; Luciana Nichita; Razvan Andrei; Tiberiu Tebeica; Cristiana Tanase; Virginia Chitu; Constantin Caruntu; Mihaela Ghita; Catalin Popescu; Daniel Boda; Bogdan Mastalier; Nicoleta Maru; Claudiu Daha; Bogdan Andreescu; Ioan Marinescu; Adrian Rebosapca; Florica Staniceanu; Gabriela Negroiu; Daniela A Ion; Dragana Nikitovic; George N Tzanakakis; Demetrios A Spandidos; Aristidis M Tsatsakis
Journal:  Oncol Lett       Date:  2016-03-29       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.